COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2500 participants.
Also called NCT05873881
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 2,500 participants
- Sponsor
- Registry
-
NCT05873881
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Recruiting
Technical summary
Registry record NCT05873881. Randomized; double masking; primary purpose treatment. Start 2024-01-29 (actual); primary completion 2027-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease
- Acronym
- COLT-HF
- Condition
- Heart Failure
- Intervention (Drug)
- Colchicine 0.5 MG
- Intervention (Drug)
- Colchicine placebo
- Intervention (Drug)
- Thiamine Mononitrate 300 mg
- Lead sponsor
- Hamilton Health Sciences Corporation
- Collaborator
- Population Health Research Institute
- Collaborator
- Canadian Institutes of Health Research (CIHR)
Record details
- Record id
cardio:ct-nct05873881- Content hash
6eeff744c9d8b32dcdf0e142ee3f1db7003a5b4899f9090c5f970b2bfc6af997